论文部分内容阅读
辉瑞董事长兼总经理史帝尔认为,药厂的推销员比经商更容易博得客户的信任。因此,辉瑞有自己的行销班底。美国辉瑞药厂的壮阳药“威而钢”有对手了,美国亚培药厂与日本武田制药正共同研发威力更大的壮阳药 Apomorphine,目前已到了临床试验阶段。预计一九九九年便可以上市,要与威而钢一拼高下.辉瑞董事长兼总经理史帝尔(William Steere)知道这场仗硬是冲着他来,对手的目标是要抢夺全球患有性功能障碍男性的市场。
Steve, chairman and general manager of Pfizer, believes pharmaceutical salespeople win customers’ trust more easily than doing business. Therefore, Pfizer has its own marketing team. The United States Pfizer aphrodisiac “Granville and steel, ” an opponent, the United States Abbott Laboratories and Japan’s Takeda are working together to develop more powerful aphrodisiac Apomorphine, has now reached the clinical trial phase. It is estimated that it will be available for sale in 1999 and compete with Vaillant Steel, Inc. Pfizer chairman and managing director William Steere knows it’s the battle against him and his goal is to grab the world Men with sexual dysfunction in the market.